Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanomaPatricia Reyes-Uribe, Jessie Villanueva|Oncogene|2018Cited by 54
Selective abrogation of S6K2 identifies lipid homeostasis as a survival vulnerability in MAPK inhibitor–resistant <i>NRAS</i> -mutant melanomaBrittany C. Lipchick, Jessie Villanueva|Science Translational Medicine|2025Cited by 4